-
公开(公告)号:US10342244B2
公开(公告)日:2019-07-09
申请号:US15829142
申请日:2017-12-01
Applicant: ABBOTT LABORATORIES
Inventor: Bridget Barrett-Reis , Pamela T. Price , Amy Mackey
Abstract: Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk of retinopathy of prematurity in preterm infants.
-
公开(公告)号:US09861120B2
公开(公告)日:2018-01-09
申请号:US14512144
申请日:2014-10-10
Applicant: ABBOTT LABORATORIES
Inventor: Bridget Barrett-Reis , Pamela T. Price , Amy Mackey
CPC classification number: A23L2/66 , A23L33/10 , A23L33/115 , A23L33/17 , A23L33/40 , A23V2002/00 , G01N33/82 , G01N2800/38
Abstract: Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk of retinopathy of prematurity in preterm infants.
-